Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PureHoney Technologies is a specialized contract research organization (CRO) that provides high-throughput screening (HTS) and drug discovery services using advanced mass spectrometry. The company leverages its proprietary RapidFire MS platform to develop label-free functional and binding assays for challenging biological targets, including enzymes, transporters, and protein-protein interactions. By eliminating the need for fluorescent or radioactive labels, PureHoney enables more physiologically relevant screening and lead optimization for pharmaceutical and biotechnology partners. Their expertise allows for the analysis of native substrates and products, significantly accelerating the drug discovery process for complex biochemical pathways.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pure Raw Honey.